Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Not applicableUnknownNCT04324866
What this trial is testing

Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

Who this might be right for
Coronavirus Infection
Universita di Verona 300
Testing effectiveness (Phase 2)Study completedNCT01246583
What this trial is testing

CP-690-550 Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 71
Post-approval studies (Phase 4)Study completedNCT00168753
What this trial is testing

Community Based Trial for AMEVIVE®

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Astellas Pharma Inc 114
Testing effectiveness (Phase 2)Study completedNCT00678210
What this trial is testing

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 197
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Not applicableStudy completedNCT02786186
What this trial is testing

A Registry of Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 2,376
Large-scale testing (Phase 3)Active Not RecruitingNCT03451851
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableTemporarily pausedNCT01279629
What this trial is testing

Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Glenmark Farmacêutica Ltda 50
Large-scale testing (Phase 3)Study completedNCT00673556
What this trial is testing

Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 195
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Testing effectiveness (Phase 2)Study completedNCT01987843
What this trial is testing

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tanabe Pharma Corporation 142
Not applicableWithdrawnNCT01758705
What this trial is testing

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott)
Not applicableStudy completedNCT01076192
What this trial is testing

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 547
Early research (Phase 1)Study completedNCT04163016
What this trial is testing

A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisCrohn's Disease+2 more
UCB Biopharma SRL 22
Early research (Phase 1)Study completedNCT03922607
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 65
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Next Page